doi: 10.3727/096368915X690279 107 DalySCChemmanamTLohPSGilliganADearAESimpsonRWet al
Weight loss medications may not be appropriate for everyone and can cause serious side effects
Microbial Ecology, 75 (1), 228-238
Kidney Issues GLP-1 drugs can sometimes impact kidney function, manifesting as: Dehydration, often due to nausea and vomiting Changes in urination patterns Swelling in the legs or ankles Patients with pre-existing kidney conditions should discuss GLP-1 treatments with their healthcare provider to assess potential risks
Common GLP-1 receptor agonist medications include semaglutide drugs such as Ozempic, Wegovy, and Rybelsus, as well as tirzepatide medications including Mounjaro and Zepbound
Because vaginal endpoints are not systematically collected or reported as key outcomes in major semaglutide trials in publicly available labelling, much of the question depends on indirect evidence and signal detection